2025-01-05 2026-01-31 false Capium Accounts Production 1.1 16162554 2025-01-05 2026-01-31 16162554 bus:FullAccounts 2025-01-05 2026-01-31 16162554 bus:FRS102 2025-01-05 2026-01-31 16162554 bus:AuditExemptWithAccountantsReport 2025-01-05 2026-01-31 16162554 bus:SmallCompaniesRegimeForAccounts 2025-01-05 2026-01-31 16162554 bus:PrivateLimitedCompanyLtd 2025-01-05 2026-01-31 16162554 2025-01-05 2026-01-31 16162554 2026-01-31 16162554 bus:RegisteredOffice 2025-01-05 2026-01-31 16162554 core:WithinOneYear 2026-01-31 16162554 core:AfterOneYear 2026-01-31 16162554 1 2025-01-05 2026-01-31 16162554 bus:Director1 2025-01-05 2026-01-31 16162554 bus:Director1 2026-01-31 16162554 2024-01-05 16162554 bus:LeadAgentIfApplicable 2025-01-05 2026-01-31 16162554 2025-01-04 16162554 bus:OrdinaryShareClass1 2025-01-05 2026-01-31 16162554 bus:OrdinaryShareClass1 2026-01-31 16162554 core:MotorCars 2025-01-05 2026-01-31 16162554 core:MotorCars 2026-01-31 16162554 core:MotorCars 2025-01-04 16162554 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-01-31 16162554 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-04 16162554 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 16162554 core:CostValuation core:Non-currentFinancialInstruments 2025-01-04 16162554 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 16162554 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16162554 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16162554 core:Non-currentFinancialInstruments 2026-01-31 16162554 core:Non-currentFinancialInstruments 2025-01-04 16162554 core:RetainedEarningsAccumulatedLosses 2026-01-31 16162554 core:RevaluationReserve 2025-01-05 16162554 core:RevaluationReserve 2025-01-05 2026-01-31 16162554 core:RevaluationReserve 2026-01-31 16162554 core:CapitalRedemptionReserve 2025-01-05 16162554 core:CapitalRedemptionReserve 2025-01-05 2026-01-31 16162554 core:CapitalRedemptionReserve 2026-01-31 16162554 core:RetainedEarningsAccumulatedLosses 2025-01-05 16162554 core:RetainedEarningsAccumulatedLosses 2025-01-05 2026-01-31 16162554 core:RetainedEarningsAccumulatedLosses 2026-01-31 16162554 dpl:Item1 2025-01-05 16162554 dpl:Item1 2026-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 16162554


 

 

 

BENBRUSI MEDICAL SERVICES LIMITED



Unaudited Financial Statements
 


Period of accounts

Start date: 05 January 2025

End date: 31 January 2026
Director Benjamin UGHWUBRUSI
Registered Number 16162554
Registered Office 11 Rose Avenue
Wigan
WN6 8QX
Accountants SRT Accounting Services Ltd
83 Heathbank Road
Higher Blackley
Manchester
M9 0WB
Bankers Natwest



1
Director's report and financial statements
The director presents his/her/their annual report and the financial statements for the year ended 31 January 2026.
Principal activities
Principal activity of the company during the financial period was of Medical Services
Director
The director who served the company throughout the period was as follows:
Benjamin UGHWUBRUSI
Statement of director's responsibilities
The director is responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice.
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.

In preparing these financial statements, the director is required to :
  • select suitable accounting policies and then apply them consistently
  • make judgements and accounting estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions

On behalf of the board.


----------------------------------
Benjamin UGHWUBRUSI
Director

Date approved: 09 May 2026
2
Report to the directors on the preparation of the unaudited statutory accounts of Benbrusi Medical Services Limited for the year ended 31 January 2026.
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Benbrusi Medical Services Limited for the year ended 31 January 2026 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at
http://rulebook.accaglobal.com/.
This report is made solely to the Board of Directors of Benbrusi Medical Services Limited, as a body, in accordance with the terms of our engagement letter dated 09 May 2026. Our work has been undertaken solely to prepare for your approval the accounts of Benbrusi Medical Services Limited and state those matters that we have agreed to state to the Board of Directors of Benbrusi Medical Services Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Benbrusi Medical Services Limited and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Benbrusi Medical Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Benbrusi Medical Services Limited. You consider that Benbrusi Medical Services Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Benbrusi Medical Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts
31 January 2026.



....................................................

SRT Accounting Services Ltd

83 Heathbank Road
Higher Blackley
Manchester
M9 0WB
09 May 2026
3
 
 
Notes
 
2026
£
Turnover 316,933 
Cost of sales (55,503)
Gross profit 261,430 
Administrative expenses (189,675)
Operating profit 71,755 
Profit/(Loss) on ordinary activities before taxation 71,755 
Tax on profit on ordinary activities (14,109)
Profit/(Loss) for the financial period 57,646 
 
4
 
 
Notes
 
2026
£
Fixed assets    
Tangible fixed assets 3 78,590 
78,590 
Current assets    
Cash at bank and in hand 75,278 
Creditors: amount falling due within one year 4 (66,062)
Net current assets 9,216 
 
Total assets less current liabilities 87,806 
Creditors: amount falling due after more than one year 5 (80,160)
Net assets 7,646 
 

Capital and reserves
   
Profit and loss account 7,646 
Shareholders' funds 7,646 
 


For the period ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the director on 09 May 2026 and were signed by:


-------------------------------
Benjamin UGHWUBRUSI
Director
5
  Revaluation reserve   Capital redemption reserve   Retained Earnings   Total
£ £ £ £
At 05 January 2025
Profit for the period 57,646  57,646 
Total comprehensive income for the period 57,646  57,646 
Dividends (50,000) (50,000)
Total investments by and distributions to owners (50,000) (50,000)
At 31 January 2026 7,646  7,646 
6
General Information
Benbrusi Medical Services Limited is a private company, limited by shares, registered in , registration number 16162554, registration address 11 Rose Avenue, Wigan, WN6 8QX .

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles 20 Straight Line
2.

Average number of employees

Average number of employees during the period was 5.
3.

Tangible fixed assets

Cost or valuation Motor Vehicles   Total
  £   £
At 05 January 2025  
Additions 80,160    80,160 
Disposals  
At 31 January 2026 80,160    80,160 
Depreciation
At 05 January 2025  
Charge for period 1,570    1,570 
On disposals  
At 31 January 2026 1,570    1,570 
Net book values
Closing balance as at 31 January 2026 78,590    78,590 
Opening balance as at 05 January 2025  


4.

Creditors: amount falling due within one year

2026
£
Corporation Tax 14,109 
Dividends Payable - Equity 50,000 
Directors' Current Accounts 1,953 
66,062 

5.

Creditors: amount falling due after more than one year

2026
£
Mercedes-Benz FS 40,160 
Directors' Loan Accounts 40,000 
80,160 

6.

Share Capital

Allotted, called up and fully paid
2026
£
1 Class A share of £1.00 each

7